MediWound (NASDAQ:MDWD) Share Price Passes Above Fifty Day Moving Average - Should You Sell...
MarketBeat·19h ago
More News
MediWound Ltd. (NASDAQ:MDWD) Given Average Rating of "Hold" by Brokerages
Shares of MediWound Ltd. (NASDAQ:MDWD - Get Free Report) have earned an average recommendation of "Hold" from the five analysts that are covering the company, Marketbeat reports. One equities...
MarketBeat·9d ago
MediWound (NASDAQ:MDWD) Stock Passes Below 200-Day Moving Average - Time to Sell?
Menora Mivtachim Holdings LTD. increased its position in MediWound Ltd. (NASDAQ:MDWD - Free Report) by 348.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·30d ago
Rosalind Advisors Inc. Buys 341,993 Shares of MediWound Ltd. $MDWD
Rosalind Advisors Inc. boosted its stake in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) by 84.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·30d ago
FY2030 Earnings Forecast for MediWound Issued By Maxim Group
MediWound Ltd. (NASDAQ:MDWD - Free Report) - Equities research analysts at Maxim Group decreased their FY2030 earnings per share estimates for MediWound in a note issued to investors on Monday, March...
MarketBeat·1mo ago
MediWound (NASDAQ:MDWD) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of MediWound from a "hold" rating to a "strong sell" rating in a research report on Saturday...
MarketBeat·1mo ago
MediWound Q4 Earnings Call Highlights
MediWound (NASDAQ:MDWD) executives said 2025 marked a pivotal year for the company, highlighting progress in its late-stage EscharEx chronic wound program and the completion of an expanded...
MediWound (NASDAQ:MDWD - Get Free Report) released its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.56) EPS for the quarter, topping the consensus estimate of...
MediWound (MDWD) delivered earnings and revenue surprises of +14.07% and -10.76%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?